Avantor, Inc.
General ticker "AVTR" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $10.7B (TTM average)
Avantor, Inc. follows the US Stock Market performance with the rate: 0.0%.
Estimated limits based on current volatility of 1.8%: low 11.25$, high 11.78$
Factors to consider:
- Total employees count: 14500 as of 2022
- US accounted for 52.3% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Operational and conduct risks, Geopolitical risks, Acquisition/divestiture risks, Technological changes, Safety/environmental risks
- Current price 29.9% below estimated low
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [15.91$, 26.08$]
- 2025-12-31 to 2026-12-31 estimated range: [15.38$, 25.43$]
Financial Metrics affecting the AVTR estimates:
- Positive: with PPE of 21.2 at the end of fiscal year the price was neutral
- Positive: 7.86 < Operating profit margin, % of 15.99
- Negative: 0.79 < Interest expense per share per price, % of 1.52
- Negative: Industry operating cash flow per share per price (median), % of 0.78 <= 5.52
- Positive: Inventory ratio change, % of -0.89 <= -0.75
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 5.55
- Negative: Industry inventory ratio change (median), % of 1.55 > 0.28
- Negative: Industry earnings per price (median), % of 0 <= 0
Short-term AVTR quotes
Long-term AVTR plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $7,512.40MM | $6,967.20MM | $6,783.60MM |
| Operating Expenses | $6,382.20MM | $6,270.80MM | $5,698.80MM |
| Operating Income | $1,130.20MM | $696.40MM | $1,084.80MM |
| Non-Operating Income | $-279.10MM | $-285.90MM | $-230.90MM |
| Interest Expense | $265.80MM | $284.80MM | $218.80MM |
| Income(Loss) | $851.10MM | $410.50MM | $853.90MM |
| Taxes | $164.60MM | $89.40MM | $142.40MM |
| Profit(Loss)* | $686.50MM | $321.10MM | $711.50MM |
| Stockholders Equity | $4,855.40MM | $5,252.60MM | $5,956.70MM |
| Inventory | $913.50MM | $828.10MM | $731.50MM |
| Assets | $13,464.30MM | $12,972.70MM | $12,114.50MM |
| Operating Cash Flow | $843.60MM | $870.00MM | $840.80MM |
| Capital expenditure | $133.40MM | $146.40MM | $148.80MM |
| Investing Cash Flow | $-109.60MM | $-143.70MM | $438.90MM |
| Financing Cash Flow | $-648.70MM | $-843.70MM | $-1,281.20MM |
| Earnings Per Share** | $1.05 | $0.48 | $1.05 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.